Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) Enterprise Value (2019 - 2025)

Historic Enterprise Value for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to -$75.9 million.

  • Strata Critical Medical's Enterprise Value rose 4431.63% to -$75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.9 million, marking a year-over-year increase of 4431.63%. This contributed to the annual value of -$124.8 million for FY2024, which is 2486.38% up from last year.
  • As of Q3 2025, Strata Critical Medical's Enterprise Value stood at -$75.9 million, which was up 4431.63% from -$113.4 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Enterprise Value registered a high of -$7.5 million during Q1 2021, and its lowest value of -$333.2 million during Q2 2021.
  • Moreover, its 5-year median value for Enterprise Value was -$169.7 million (2023), whereas its average is -$178.7 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 3322699.03% in 2021, then surged by 4431.63% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's Enterprise Value stood at -$282.0 million in 2021, then skyrocketed by 31.88% to -$192.1 million in 2022, then grew by 13.51% to -$166.1 million in 2023, then increased by 24.86% to -$124.8 million in 2024, then skyrocketed by 39.18% to -$75.9 million in 2025.
  • Its Enterprise Value was -$75.9 million in Q3 2025, compared to -$113.4 million in Q2 2025 and -$120.0 million in Q1 2025.